Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
NCT04220996
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
MDD
Anxiety Disorders
Interventions
DRUG:
Vortioxetine
Sponsor
H. Lundbeck A/S